Robert J. DeVita
Abterra Biosciences (United States)(US)Drug Discovery Laboratory (Norway)(NO)New York University(US)Icahn School of Medicine at Mount Sinai(US)
Publications by Year
Research Areas
Metabolism and Genetic Disorders, Biochemical and Molecular Research, Synthesis and Biological Evaluation, Pancreatic function and diabetes, Asymmetric Synthesis and Catalysis
Most-Cited Works
- → Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure(2015)125 cited
- → GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration(2020)119 cited
- → Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction(2016)106 cited
- → Current Status of the Research and Development of Diacylglycerol O-Acyltransferase 1 (DGAT1) Inhibitors(2013)100 cited
- → Enantioselective total synthesis of neooxazolomycin(1990)94 cited
- → Food colorants metabolized by commensal bacteria promote colitis in mice with dysregulated expression of interleukin-23(2021)90 cited